DrugPatentWatch Database Preview
Atlas Pharms Llc Company Profile
What is the competitive landscape for ATLAS PHARMS LLC, and what generic and branded alternatives to ATLAS PHARMS LLC drugs are available?
ATLAS PHARMS LLC has two approved drugs.
Summary for Atlas Pharms Llc
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Atlas Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Atlas Pharms Llc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 076033-003 | Jan 24, 2002 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Atlas Pharms Llc | IRBESARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; irbesartan | TABLET;ORAL | 203036-002 | Jan 15, 2016 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Atlas Pharms Llc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 076033-001 | Jan 24, 2002 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Atlas Pharms Llc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET;ORAL | 076033-002 | Jan 24, 2002 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Atlas Pharms Llc | IRBESARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; irbesartan | TABLET;ORAL | 203036-001 | Jan 15, 2016 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Atlas Pharms Llc | IRBESARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; irbesartan | TABLET;ORAL | 203036-003 | Jan 15, 2016 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
